What is it about?
In this article role of glucagon and glucagon-like peptide-1 (GLP-1) receptors in diabetes condition is discussed. Most promising antagonist of glucagon receptor and agonist of glucagon-like peptide-1 receptor are highlighted for the management of diabetes mellitus.
Featured Image
Why is it important?
The article helps to increase our understanding about diabetes- mellitus which is one of the most challenging diseases of present era. The compounds with potent anti-diabetic potential are presented and their mechanism of action is discussed.
Perspectives
I hope this article will provide insight about diabetes mellitus, I am sure, it will encourage health related researchers and industries to consider possible future therapies against diabetes melltus.
Ghulam Abbas
University of Nizwa, Oman
Read the Original
This page is a summary of: Glucagon and Glucagon-like Peptide-1 Receptors: Promising Therapeutic Targets for an Effective Management of Diabetes Mellitus, Current Pharmaceutical Design, March 2020, Bentham Science Publishers,
DOI: 10.2174/1381612826666200131143231.
You can read the full text:
Contributors
The following have contributed to this page
